Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Earnings data Q1 2026

Earnings data Q2 2026

Earnings data Q3 2026

Earnings data Q4 2026

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Tilray Brands reports robust Q2 growth, eyes $1B revenue milestone

Tilray Brands demonstrated solid growth in Q2 with strong revenue performance across key business segments, underpinned by strategic initiatives and global expansion.
While facing challenges in managing costs and sustaining profitability, the company remains optimistic about future growth prospects and market opportunities.
With a focus on innovation, market readiness, and revenue guidance for fiscal 2025, Tilray Brands is poised for continued success and market leadership in the evolving cannabis industry.

Tilray reports strong Q3 earnings, eyes global growth opportunities

Tilray Brands showcased solid financial performance in Q3 2025, emphasizing growth in revenue, profit, and margin improvements amidst market challenges. The company's strategic transformation to a diversified consumer products company and focus on sustainable global growth position it for long-term success and profitability. Despite facing challenges such as declining cannabis revenues, Tilray is leveraging opportunities in the beverage business, EU market, and operational efficiencies to drive growth.

Tilray Brands reports record revenue and strategic growth plans for 2026

Tilray Brands delivered strong financial results in Q4 2025, focusing on international and Canadian markets, cost optimization, and strategic initiatives. Despite challenges like regulatory changes and legislative impacts, the company remains optimistic about growth prospects in 2026. With a strong balance sheet, diversified business, and focus on profitability, Tilray is well-positioned to capitalize on growth opportunities in the cannabis industry.

Tilray reports $210M revenue in Q1 2026, eyes global expansion

Tilray Brands delivered solid financial performance in Q1 2026, driven by revenue growth in key segments and effective debt management. The company's diverse brand portfolio and global presence provide a strong foundation for future growth and market leadership. While facing challenges in operational efficiency and profitability, Tilray has opportunities to innovate, expand product offerings, and capitalize on the growing cannabis market.

Tilray reports record Q2 revenue, eyes U.S. expansion opportunities

Tilray Brands (TLRY) delivered strong financial performance in Q2 2026, with record net revenue and a focus on global market expansion. Despite challenges such as regulatory uncertainties and competition, the company's strategic positioning and operational strengths are notable. Opportunities lie in potential U.S. market developments, international growth, and product diversification for future success and value creation.

Tilray Brands (TLRY) posts record Q3 earnings, eyes global expansion

Tilray Brands (TLRY) reported strong financial performance in Q3 2026, driven by record revenue and profit figures. Strategic acquisitions and partnerships position the company for further growth in the global cannabis and craft beverage markets. While facing challenges in integration and regulatory uncertainties, Tilray remains optimistic about its future prospects and market positioning.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.